Leadership Overview
ELIQUENT Life Sciences Inc has 5 executives leading key functions including strategy, finance, operations, engineering, and market authorization.
Driven by a commitment to simplifying regulatory complexity, ELIQUENT Life Sciences Inc partners with life sciences innovators to secure and maintain market authorizations, leveraging deep domain expertise and integrated solutions across regulatory affairs, quality, pharmacovigilance, and technical strategy.
Driven by a commitment to simplifying regulatory complexity, ELIQUENT Life Sciences Inc partners with life sciences innovators to secure and maintain market authorizations, leveraging deep domain expertise and integrated solutions across regulatory affairs, quality, pharmacovigilance, and technical strategy.
Leadership Roles at ELIQUENT Life Sciences Inc
Patrick Ronan - Chief Executive Officer
Patrick Ronan, the Chief Executive Officer at ELIQUENT Life Sciences Inc, directs the overarching corporate strategy and market positioning. Ronan guides the firm's mission to simplify regulatory complexity for life sciences innovators, ensuring market authorizations are secured efficiently. This leadership involves aligning the company's integrated solutions across regulatory affairs, quality and compliance, pharmacovigilance, and technical strategy. Ronan's focus centers on fostering a culture of deep domain expertise and regulatory acumen among industry experts and former regulators. The Chief Executive Officer drives the company's global expansion and client engagement efforts, solidifying ELIQUENT Life Sciences Inc's role as a premier partner in the life sciences sector. Patrick Ronan's strategic vision ensures continuous adaptation to evolving regulatory landscapes, maintaining the firm's competitive edge and client success.
Stephen Purtell - Chief Financial Officer
Stephen Purtell, the Chief Financial Officer at ELIQUENT Life Sciences Inc, oversees all financial operations and strategic fiscal planning. Purtell manages the company's financial health, ensuring robust resource allocation to support integrated solutions in regulatory affairs, quality and compliance, pharmacovigilance, and technical strategy. The Chief Financial Officer drives financial performance, analyzing market trends and economic factors to optimize profitability and investment. Stephen Purtell's responsibilities include managing investor relations, securing capital, and implementing financial controls that uphold ELIQUENT Life Sciences Inc's commitment to client success and market authorizations. This role is critical in maintaining the company's operational stability and facilitating its growth within the global life sciences consulting sector. Purtell's financial acumen directly supports the firm's ability to deliver tailored support and deep domain expertise.

Allison Kerska - President, Engineering Practice
Allison Kerska, the President, Engineering Practice at ELIQUENT Life Sciences Inc, leads the technical strategy and engineering solutions for clients. Kerska directs the development and implementation of innovative engineering approaches that support product development and regulatory compliance within the life sciences sector. The President, Engineering Practice ensures that technical strategies align with market authorization requirements and the company's overall mission to simplify regulatory complexity. Allison Kerska's leadership focuses on leveraging deep domain expertise to provide tailored support for complex engineering challenges. This role is crucial for integrating engineering capabilities with regulatory affairs, quality and compliance, and pharmacovigilance services. Kerska's oversight guarantees that ELIQUENT Life Sciences Inc offers cutting-edge technical guidance, reinforcing its position as a comprehensive partner for life sciences innovators.

John Taylor - President
John Taylor, the President at ELIQUENT Life Sciences Inc, drives market engagement and client relationship management. Taylor oversees the strategic expansion of ELIQUENT Life Sciences Inc's services, ensuring that life sciences innovators receive comprehensive support for market authorizations. The President focuses on enhancing the delivery of integrated solutions spanning regulatory affairs, quality and compliance, pharmacovigilance, and technical strategy. John Taylor's leadership emphasizes the firm's commitment to simplifying regulatory complexity through deep domain expertise and tailored client support. This role is pivotal in fostering strong partnerships and communicating the value proposition of ELIQUENT Life Sciences Inc to the global market. Taylor's strategic direction ensures sustained growth and reinforces the company's reputation as a trusted advisor in the life sciences industry.
David Candito - Chief of Staff
David Candito, the Chief of Staff at ELIQUENT Life Sciences Inc, enhances operational efficiency and strategic execution across the organization. Candito facilitates seamless collaboration between departments, ensuring the company's integrated solutions in regulatory affairs, quality and compliance, pharmacovigilance, and technical strategy are delivered cohesively. The Chief of Staff manages key strategic initiatives and special projects, driving progress towards ELIQUENT Life Sciences Inc's mission of simplifying regulatory complexity for life sciences innovators. David Candito's role involves optimizing internal processes and supporting executive leadership in achieving critical business objectives. This position is vital for maintaining the agility and responsiveness required to navigate the dynamic regulatory lifecycle and provide tailored support. Candito's efforts ensure that the deep domain expertise of the team translates into tangible client success.
Explore Leadership Teams in Business Services
Working exclusively with the CEOs and senior executives of the worlds leading companies, Teneo provides strategic counsel across their full range of key objectives and issues. Our clients include a significant number of the Fortune 100 and FTSE 100, as well as other corporations, financial institutions and organizations.
Company Leadership CF

BC

Marquis Health Consulting Services provides administrative and consulting services to skilled nursing facilities and Senior Housing communities throughout the United States Eastern Seaboard
Company Leadership BM
AG
CS
MP
CRA International, Inc., together with its subsidiaries, provides economic, financial, and management consulting services worldwide. It advises clients on economic and financial matters pertaining to litigation and regulatory proceedings; and guides corporations through business strategy and performance-related issues. The company also offers consulting services, including research and analysis, expert testimony, and support in litigation and regulatory proceedings in the areas of finance, accounting, economics, insurance, and forensic accounting and investigations to corporate clients and attorneys. In addition, it offers management consulting services comprising strategy development, performance improvement, corporate strategy and portfolio analysis, estimation of market demand, environmental, social and corporate governance and sustainability strategy and analysis, design and implementation of auction and bidding, new product pricing strategies, survey and market research, valuation of intellectual property and other assets, assessment of competitors' actions, and analysis of new sources of supply. The company serves various industries, including communications and media; consumer, health, and wellness products; energy; entertainment and leisure; financial services; healthcare; life sciences; manufacturing and industries; natural resources; retail and distribution; technology; and transportation. CRA International, Inc. was incorporated in 1965 and is headquartered in Boston, Massachusetts.
Company Leadership


CareAllies provides consulting services for health care providers to improve quality, value, and experience of care for patients. CareAllies was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
Company Leadership JD
JN
EM
RC